Fig. 3From: Thy-1 predicts poor prognosis and is associated with self-renewal in ovarian cancerThy-1 is associated with poorer clinical outcomes in women with ovarian cancer. High expression of Thy-1 is associated with poorer progression-free and overall survival in serous ovarian cancer (a, b), and poorer progression-free survival, but not overall survival in endometrioid ovarian cancer (c, d)Back to article page